ResMed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. 

CEO
Michael J. Farrell
CEOMichael J. Farrell
Employees
10,600
Employees10,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1989
Founded1989
Employees
10,600
Employees10,600

RMD Key Statistics

Market cap
29.29B
Market cap29.29B
Price-Earnings ratio
19.46
Price-Earnings ratio19.46
Dividend yield
1.15%
Dividend yield1.15%
Average volume
1.46M
Average volume1.46M
High today
$206.00
High today$206.00
Low today
$201.47
Low today$201.47
Open price
$204.15
Open price$204.15
Volume
1.40M
Volume1.40M
52 Week high
$293.81
52 Week high$293.81
52 Week low
$198.61
52 Week low$198.61

Stock Snapshot

The current ResMed(RMD) stock price is $201.88, with a market capitalization of 29.29B. The stock trades at a price-to-earnings (P/E) ratio of 19.46 and offers a dividend yield of 1.2%.

As of 2026-05-17, ResMed(RMD) stock has fluctuated between $201.47 and $206.00. The current price stands at $201.88, placing the stock +0.2% above today's low and -2.0% off the high.

ResMed(RMD) shares are trading with a volume of 1.4M, against a daily average of 1.46M.

During the past year, ResMed(RMD) stock moved between $198.61 at its lowest and $293.81 at its peak.

During the past year, ResMed(RMD) stock moved between $198.61 at its lowest and $293.81 at its peak.

RMD News

TipRanks 2d
Analyst Maintains Hold on ResMed as Noctrix Acquisition Offers Limited Incremental Growth Amid Competitive Risks

Needham analyst Michael Matson has maintained their neutral stance on RMD stock, giving a Hold rating on May 6. Claim 55% Off TipRanks Unlock hedge fund-level d...

TipRanks 5d
ResMed CEO Farrell Exercises Options and Trims Stake Under 10b5-1 Plan

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Simply Wall St 6d
How Investors May Respond To ResMed Leadership Shift And Capital Return Milestones

In late April 2026, ResMed reported higher third‑quarter and nine‑month sales and earnings, confirmed a US$0.60 quarterly dividend, completed its long-running s...

How Investors May Respond To ResMed Leadership Shift And Capital Return Milestones

Analyst ratings

68%

of 28 ratings
Buy
67.9%
Hold
25%
Sell
7.1%

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.